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Introduction: The aim is to evaluate the effect of robot-assisted training on the most important 
aspects of functioning and disability in patients with upper extremity neurologic impairment. 
Materials and Methods: A prospective six-week pilot study included robot-assisted training of the 
upper extremity and conventional neurorehabilitation in 12 participants after a stroke or traumatic 
brain injury. Outcome measurements were range of motion (ROM), the International Classification of 
Functioning, Disability and Health (ICF) Core Set for Hand and the Visual Analog Scale (VAS) for pain 
sensation. A Wilcoxon test was used for the analysis of pre- and post-test differences and 
Spearman’s correlation was used for connecting the data collected. 
Results: A statistically significant difference was found for ROM (shoulder abduction/adduction, 
shoulder flexion/extension, shoulder internal/external rotation and forearm pronation/supination) 
and a number of ICF categories (Body Function: b280, b710, b715, b730, b760; Activities and 
Participation: d230, d430, d440, d445, d5). A significant positive correlation of medium intensity 
(r=0.589) was found between the duration of movement coordination training and the ICF category 
b760. We did not find a statistically significant difference in pain sensation (VAS) with regard to the 
direct use of the device. For all analyses, p<0.05 and CI was 95%. 
Conclusion: Robot-assisted training and conventional neurorehabilitation improved motor and 
functional recovery. There was a correlation between training a specific goal on the device and one 
of the ICF Body Function categories. 
 
(Blažinčić V, Ščurić I, Klepo I, Dubroja I, Cerovec D. Effects of Robot-assisted Upper Extremity 
Rehabilitation on Change in Functioning and Disability in Patients With Neurologic Impairment: A Pilot 
Study. SEEMEDJ 2021; 5(1); 96-108) 
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Introduction 
Advances in medicine are impossible without 
the combined effort of advances in different 
technologies. Today, the use of novel 
technology in medicine is expected. Since 2011, 
an upper extremity exoskeleton has been 
commercially accessible for rehabilitation (1). 
But how can we recognise and subsequently 
combine the clinical needs of patients with the 
corresponding devices (2)? Robot-assisted 
devices for the upper extremity have been 
created for training and assisting or can combine 
these two functions (3). According to the World 
Health Organization, stroke, traumatic brain 
injury (TBI) and spinal cord injury (SCI) are 
defined as chronic diseases (4). While various 
neurological conditions affect different 
populations and have different pathophysiology, 
they all damage neural networks and motor 
system networks in particular. As such, clinical 
impairment and functional problems of persons 
with different neurological conditions can often 
overlap (5) and analysing them together may be 
of interest (6). Around 70% of patients with stroke 
(7) and 30% of patients with TBI exhibit upper 
extremity paresis at rehabilitation admission 
(8,9). For restoration of upper extremity function 
in patients with a neurologic deficit, the main 
therapy strategies target the impaired motor 
cortex (activation of ipsilateral or inhibition of 
contralateral) or affect afferent sensory 
pathways (10). It is well-recognised that an 
intense training program during rehabilitation for 
patients in the subacute period (i.e. in the first 6 
months) will significantly improve functional 
outcomes for the upper extremity (10.11). Meta-
analyses have demonstrated significant effects 
on motor control and muscle strength using 
shoulder/elbow robotics, as well as on motor 
control using elbow/wrist robotics (12). For 
persons with neurological deficits in a chronic 
phase, robot-assisted rehabilitation is more 
effective than other types of therapies for 
recovery of upper extremity motor function (13). 
Together, these results indicate that the use of 
an exoskeleton device with various possibilities 
(virtual reality, augmented reality and 
gamification) lead to general improvement of 
motoric function in neurorehabilitation (14). But 
can it lead to an improvement in overall 
functional status? In the present study, we 
decided to use the International Classification of 
Functioning and Disability (ICF) as a 
measurement tool in light of the notion that 
limitations of function and disability are not only 
related to aetiology, but can also be considered 
as general manifestations in overall health 
conditions (15). The ICF also has other 
advantages in its use of a common language (i.e. 
it is internationally comparable) (16) and has the 
essential and most relevant categories for 
personal functioning when using the ICF Core 
Set information (17). The first aim of this 
investigation is to assess the efficacy of robot-
assisted training on the motoric function of the 
upper extremity. Secondly, this study aims to 
examine change in functioning and disability 
among persons with upper extremity 
impairment caused by different neurologic 
aetiology at a clinical level during inpatient 
rehabilitation. The first expected effect of robot-
assisted training is an increase in the range of 
motion (ROM) of joints in the trained upper 
extremity and changes in activity and 
participation among the participants. The 
second expected effect is a connection 
between the time spent in training specific goals 
on the robot-assisted device and selected body 
domains of the ICF Core Set. Pain sensation in 
the trained extremity will also be evaluated. 
 
Materials and Methods  
This prospective pilot study was conducted at 
the Special Hospital for Medical Rehabilitation 
Krapinske Toplice in Croatia.  
Prior to the commencement of the study, 
informed consent was obtained from all 
participants and the study was conducted 
according to the Helsinki Declaration. Consent 
for publication of the study results was obtained 
from the Ethical Committee of the Special 
Hospital for Medical Rehabilitation Krapinske 
Toplice.Twelve participants (3 women and 9 
men) aged between 20 and 61 years who 
underwent acute neurorehabilitation following a 
traumatic brain injury or stroke met the inclusion 
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criteria. Inclusion criteria were: aged 18 years and 
older, paresis of the upper extremity following a 
traumatic brain injury or stroke, ability to sit (i.e., 
exhibits trunk control in a sitting position) and a 
Rancho level of function of 5 or more. Exclusion 
criteria were: non-acute rehabilitation phase, 
paresis of the upper extremity of other aetiology, 
plegia of the upper extremity, inability to sit (i.e., 
exhibits inadequate trunk control in sitting 
position), fixed contractures of shoulder, elbow 
or wrist joints, a Rancho level of function less 
than 5, apraxia, hemineglect and receptive 
aphasia. The study was designed as a six-week 
program. Participants received robot-assisted 
training during their regular occupational 
therapy sessions for 30 minutes, 5 days a week. 
All participants were assessed at the beginning 
and at the end of the study. Our primary 
outcome measurements were ROM (for 
shoulder and elbow joints) and categories of the 
ICF Core Set - Hand Conditions Brief (for the 
trained upper extremity). The evaluation of pain 
sensation in the trained upper extremity was a 
secondary outcome measurement. For the 
assessment of ROM, kinematic parameters of 
the shoulder and elbow joints (i.e. minimal and 
maximal shoulder abduction/adduction, 
minimal and maximal shoulder 
flexion/extension, minimal and maximal 
inner/outer shoulder rotation, minimal and 
maximal elbow flexion/extension and minimal 
and maximal forearm pronation/supination) 
recorded during training on the robot-assisted 
device were collected and analysed. 
Assessment of the selected ICF Core Set was 
conducted by one investigator following 
additional education. The ICF Core Set is made 
up of 23 categories (9 in Body Function, 3 in Body 
Structures, 8 in Activities and Participation and 3 
in Environmental Factors). Every category was 
assessed using the ICF qualifiers on an ordinal 
scale ranging from 0 (no impairment) to 4 
(complete impairment), with additional possible 
values of 8 (not specified) and 9 (not applicable). 
For most categories, assessment was carried 
out during clinical examination of the 
participants, while for some categories, 
information from a patient-report questionnaire 
was sufficient. Some categories also have 
additional qualifiers: Body Structures 2 (for 
nature and location of change), Activities and 
Participation 2 (for capacity and performance) 
and Environmental Factors (an). The evaluation 
of pain sensation was also carried out by one 
investigator. To assess pain directly related to 
the use of the device, the Visual Analog Scale 
(VAS) was conducted immediately before and 
after the first and last training session on the 
robot-assisted device. Prior to the beginning of 
the study, three occupational therapists were 
trained to use the robot-assisted device. An 
exoskeleton device, the Armeo®Spring 
Hocoma, Inc., composed of an upper and lower 
module for the upper arm and the forearm and 
a pressure sensitive handgrip for the hand was 
used (18). Both modules were length-adjustable, 
which allowed adequate positioning of the 
exoskeleton device and the arm joints of the 
participants. In addition, the weight 
compensation feature of exoskeleton (18) was 
utilised and individually adjusted for all 
participants. Using this exoskeleton device, our 
participants were enabled to train the shoulder 
and elbow joints, flexo-extension of the wrist 
and manual grip (19). The repetition of 
movements of the paretic upper extremity 
during virtual gaming was conducted within a 
three-dimensional workspace (18). The goals of 
robot-assisted therapy were to increase ROM 
(1D and 2D/3D), to improve movement 
coordination and to improve grasp function and 
cognitive training. All participants also 
underwent conventional neurorehabilitation (i.e. 
they received therapies individually indicated 
according to their overall clinical status, which 




Statistical evaluation was performed using 
SPSS, version 26.0 (SPSS Inc., Chicago IL, SAD). 
In the first analysis, a Wilcoxon signed-rank test 
was used to evaluate pre- and post-test 
differences for all data collected (kinematic 
parameters, ICF categories and VAS). Statistical 
significance was set at p<0.05 and CI was 95%. 
All quoted p-values are two-tailed. In the second 
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analysis, we used the Spearman’s correlation 
coefficient to test relationships in the data 
(duration of training a specific therapy goal on 
the robot-assisted device and selected ICF 
categories). A correlation greater than r>0.80 
was considered as strongly positive, 0.5<r>0.8 
was considered as medium to strongly positive 
and 0<r<0.5 was considered as weakly positive. 
A correlation coefficient greater than 0.5, r> 0.5 




All 12 participants (3 women and 9 men) 
successfully completed the pilot study. Seven 
participants (58.3%) exhibited neurologic 
impairment following TBI and 5 participants 
(41.7%) following stroke. The average age of 
participants was 39.42 years (standard deviation 
(SD) 16.94) and ranged between 20 and 61 years. 
The right arm was treated in half of the 
participants and all participants exhibited right-
hand dominance. The average number of 
therapy sessions with the robot-assisted device 
was 25.50 (SD 5.98), where the number of 
sessions ranged between 14 and 33. The 
average therapy time using the robot-assisted 
device per treatment was 13.75 minutes (SD 
2.67), ranging from 8.74 to 16.84 minutes. From 
the total number of therapies using the 
exoskeleton device, the average time spent 
performing each exercise was: 5.05 minutes (SD 
1.21) for increasing ROM 1D, with a minimal value 
of 3.16 and a maximal value of 7.43; 6.48 minutes 
(SD 1.86) for increasing ROM 2D/3D, with a 
minimal value of 4.26 and a maximal value 10.86; 
9.41 minutes (SD 2.86) for movement 
coordination, with a minimal value of 5.30 and a 
maximal value of 15.58; 2.88 minutes (SD 1.75) for 
grasp function, with a minimal value of 0.09 and 
a maximal value of 6.76; and 2.25 minutes (SD 
1.09) for cognitive training (11 participants), with a 





A Wilcoxon test showed statistically significant 
differences between the initial and final 
measurements for the following kinematics 
parameters observed: minimal shoulder 
abduction/adduction, shoulder 
abduction/adduction range of motion, minimal 
shoulder flexion/extension, shoulder 
flexion/extension range of motion, minimal 
shoulder internal/external rotation, maximal 
shoulder internal/external rotation, shoulder 
internal/external rotation range of motion, 
maximal elbow flexion/extension, minimal 
forearm pronation/supination and forearm 
pronation/supination range of motion. CI was 
95% (Table 1). 
ICF Core Set -Hand Conditions Brief 
 
A Wilcoxon test demonstrated a statistically 
significant difference between the initial and 
final assessment using the ICF Core Set for the 
following categories in Body Function: b280 
(sensation of pain), b710 (mobility of joint 
functions), b715 (stability of joint functions), b730 
(muscle power function), b760 (control of 
voluntary movement function). Similarly, 
statistically significant differences were found 
for the following categories in Activities and 
Participation: d230 (carrying out daily routine), 
d430 (lifting and carrying objects), d440 (fine 
hand use), d445 (hand and arm use) and for d5 
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Table 1. Data of the kinematics parameters (ranges of motion in degrees) for the upper extremity 
joints presented as test statisticsa 







Shoulder abd./ ad. min.  -71.14±18.82 -88.12±3.24 0.009 
Shoulder abd./ad. max. 16.09±13.50 22.61±14.29 0.117 
Shoulder abd./ad. range 86.41±26.44 110.73±16.09 0.028 
Shoulder flex./ext. min. 52.90±3.87 50.22±2.05 0.019 
Shoulder flex./ext. 
max. 
107.34±17.98 112.34±21.59 0.060 
Shoulder flex./ext. range 54.44±18.76 62.12±21.90 0.023 
Shoulder int./ext. rotation min. 32.98±18.88 18.16±17.79 0.019 
Shoulder int./ext. rotation max. 75.36±20.84 106.14±20.14 0.012 
Shoulder int./ext. rotation range 42.38±18.43 87.98±24.45 0.003 
Elbow flex./ext.  
min. 
22.72±15.32 18.62±15.81 0.241 
Elbow flex./ext. 
 max. 
94.77±11.86 102.22±6.17 0.025 
Elbow flex./ext. 
range 
   72.05±21.98 83.60±19.12 0.062 
Forearm sup./pron. min. -23.52±40.66 -48.74±27.39 0.004 
Forearm sup./pron. max. 55.45±13.19 58.49±9.29 0.285 
Forearm sup./pron. range 78.97±37.7 107.24±23.53 0.012 
a. Wilcoxon signed-rank test p <0.05 was considered significant. Abd./ab.= abduction/adduction; 
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Table 2: Data of the assessed ICF Core Set presented as test statisticsa, p<0.05 was considered 
significant. 






b152 (emotional functions) 1.50±0.52 1.42±0.52 0.317 
b265(touch function)  0.83±0.94 0.75±0.87 0.317 
b270 (sensory functions of sensing 




b280 (sensation of pain)  1.0±0.95 0.58±0.79 0.025 
b710 (mobility of joint functions)  1.92±1.24 1.17±1.12 0.014 
b715 (stability of joint functions)  1.25±1.48 0.75±1.22 0.034 
b730 (muscle power functions)  2.42±0.80 1.75±0.75 0.005 
b760 (control of voluntary movement 
functions) 
2.25±0.97 1.50±0.67 0.014 
b810 (protective functions of the skin) 0.08±0.29 0.00±0 0.317 
d230 (carrying out daily routine)  2.67±1.07 1.92±0.90 0.003 
d430 (lifting and carrying objects) 2.751±1.14 2.17±0.84 0.008 
d440 (fine hand use)  2.58±0.90 1.92±1.00 0.011 
d445 (hand and arm use)  2.33±0.65 1.50±0.52 0.002 
d5 (self –care)  2.42±1.09 1.83±1.12 0.020 
d7 p (interpersonal interactions and 
relationships)  
1.58±0.90 1.67±0.89 0.317 
d7 c (interpersonal interactions and 
relationships)  
1.08±0.79 1.08±0.79 1.000 
e1 (products and technology)  2.25±0.75 2.58±1.08 0.194 
e3 (support and relationships)  2.75±1.14 2.58±1.96 0.785 
e5 (services, system and policies)  1.83±1.12 1.00±1.35 0.655 
a. Wilcoxon signed-rank test 
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Spearman’s correlation coefficient 
demonstrated a significant positive correlation 
of medium intensity, between the duration of the 
movement coordination therapy session using 
the robot-assisted device and the ICF category 
b760, indicating a positive relationship between 
these variables r=0.589 (p-value of 0.044) (Figure 
1). No significant correlation between the 
duration of the therapy session for increasing 
ROM (1D and 2D/3D) and the ICF category b710 
was found (Table 3). 
 
Pain assessment 
A Wilcoxon test did not indicate any statistically 
significant difference in pain sensation for the 
trained upper extremity, as measured with VAS. 
CI was 95% (Table 4). 
 
Figure 1: Connection between therapy time for 
movement coordination and the ICF domain 
b760) (difference in value of control of 
voluntary movement functions) as measured 
by Spearman’s correlation coefficient 
*Correlation is significant at the 0.05 level (two-tailed). 
 
 
Table 3. Connection between therapy time, ROM 1D, ROM 2/3D and the ICF domain b710 (mobility of 
joint functions), as measured by Spearman’s correlation coefficient. 
Variable name Therapy time ROM 1D ROM 2/3D b710 (difference) 
Therapy time r  1.0  0.21  0.33 -0.21 
ROM 1D r  0.21  1.0  0.13 -0.35 
ROM 2/3D r  0.33  0.13  1.0 -0.5 
B710 (difference) r -0.21 -0.35 -0.5  1.0 
    *Correlation is significant at the 0.05 level (two-tailed). ROM 1D=range of motion, one dimension; ROM2/3D=range 
of motion, two and three dimension ICF=International Classification of Functioning, Disability and Health. 
 
 
Table 4. : Test statisticsa for pain sensation data, p<0.05 was considered significant 
Variable name Value before Value after P-value 
VAS I 13.83±24.53 10.42±13.89 0.385 
VAS II 9.17±13.95 15.33±18.36 0.327 
a. Wilcoxon signed-rank test 
VAS I= sensation of pain immediately before therapy session using the device. 
VAS II= sensation of pain immediately after therapy session using the device. 
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Discussion 
This pilot study confirmed the hypothesis that 
the use of a robot-assisted device in the 
rehabilitation of patients with paresis of the 
upper extremity leads to increased ROM in joints 
of the trained upper extremity. Other studies 
have also demonstrated motor improvement 
(ROM, strength or motor control) following 
robot-assisted training in persons with 
neurologic impairment (20-23). The added 
advantage of the robot-assisted device as an 
assessment tool (24) was used for in this study 
for measuring ROM in order to attain objective, 
quantitative data while avoiding the subjectivity 
of the investigator (25-27). In addition, another 
feature of the device – the ability to conduct a 
large number of repetitions – was used for 
improving ROM. In a study by Lo and colleagues, 
over 1,000 repetitions per session were achieved 
during a single hour of robot-assisted therapy 
(28). Because motor recovery in neurologic 
impairment is considered to depend not only on 
CNS damage, but also on the intensity (29) and 
duration of therapy, the ability to achieve a large 
number of repetitions in treatment is particularly 
important. In other words, more intense therapy 
is positively related to clinical improvements 
(30). The results of our study demonstrating a 
significant correlation between the duration of 
movement coordination therapy using the 
device and the ICF body category that describes 
control of voluntary movement are consistent 
with this evidence. But what happens when 
participants exercise ROM? The results of a 
neuroradiology study demonstrated that, when 
the sensation of movement is induced, the 
somatosensory, primary and supplementary 
motor areas of the cortex are activated and 
different proprioceptive inputs are associated 
with differently located activation patterns in 
these cortical areas (31). However, another 
important question is whether the patient will 
transfer this acquired motoric knowledge to 
everyday life? Some investigators have 
developed and tested new strategies that aim to 
facilitate the transfer of new motor skills to 
everyday activities following robot-assisted 
training (32). In this study, we used the ICF Core 
Set to understand and measure limitations in 
functioning and disability among our 
participants (33, 34) and to examine change 
following robot-assisted upper extremity 
training. The results demonstrated significant 
changes in various categories of Body Function 
and Activity and Participation. Specifically, 
participants exhibited significant improvement in 
motoric function (as measured by the robot-
assisted device and the specific ICF Core Set 
category) and had fewer limitations in 
functioning during inpatient rehabilitation (as 
measured by the ICF Core Set categories). A 
study by Goljar and colleagues demonstrated 
that the ICF categories have the potential to 
reveal time-related changes in a patient’s 
functioning (35). The ICF is also considered a 
useful framework for recognising the 
possibilities offered by devices in clinical or 
research settings (15). Our findings are consistent 
with those of others who have investigated the 
effects of robot-assisted training on functional 
recovery. In a study by Colomer and colleagues, 
significant improvement was found on both 
function and activity scales for the upper 
extremities, as measured by the Motricity Index, 
the Fugl-Meyer Assessment Scale, the Motor 
Assessment Scale, the Manual Function Test 
and the Wolf Motor Function Test (36). In another 
study using the FIM as a measurement tool, 
Daunoraviciene and colleagues found 
significant upper extremity improvement among 
participants who trained with a robotic device, as 
compared with a control group (37). The update 
of the Cochrane review by Mehrlotz and 
colleagues not only demonstrated improved 
muscle strength and function of the arm, but 
also improved scores for daily activities 
following the use of robot-assisted and 
electromechanical training in rehabilitation for 
persons after stroke (38). In regard to pain 
sensation, we did not find a significant difference 
related to the direct use of the exoskeleton 
device. In a study by Busching and colleagues, 
semi-autonomous training was used for patients 
with severe paresis and no side effects were 
found with regard to training using the same 
type of the device (39). It is possible that our 
participants did not experience changes in pain 
sensation immediately after the use of the 
exoskeleton because the degree to which the 
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upper extremity was unweighted was 
individually adjusted for all participants with the 
intention of adequately supporting the paretic 
extremity and therefore facilitating the number 
of repetitions (40).  However, when pain 
sensation is considered independently of the 
direct use of the exoskeleton device, the results 
of the ICF Core Set demonstrated a significant 
change in the domain b280 (i.e., pain sensation 
decreased for participants during the six-week 
study period). Findings from a double-blind 
randomised control study conducted by 
Taveggia and colleagues also demonstrated a 
decrease in pain sensation over a six-week study 
period for both a robot-assisted group and a 
control group (41). In our study, the degree of 
spasticity was not considered and participants 
with upper extremity contractures (including 
those related to spasticity) were not included in 
the study in accordance with the exclusion 
criteria. The main limitation of this pilot study is 
the lack of a control group due to a small 
number of participants who met the inclusion 
criteria. As such, the question remains as to the 
degree of spontaneous recovery that occurred, 
which is difficult to distinguish from therapy-
induced recovery without a control group for 
comparison. We also did not take into 
consideration new sensorimotor interactions 
between the exoskeleton device and the 
participants (42). Muscle activity and muscle 
coordination is different in healthy persons (43, 
44) when compared to persons with CNS 
damage (pathological muscle synergies and 
altered joint coordination) and, because the 
exoskeleton device has its own mechanical 
characteristics and there is kinematic 
incompatibility during the human-exoskeleton 
interaction (45), currently the intention is to have 
as little interference as possible between the 
exoskeleton and the human body. In order to be 
as ergonomic as possible, new devices aim to be 






Robot-assisted training and conventional 
neurorehabilitation improved the motor and 
functional recovery of patients with upper 
extremity paresis of various aetiology. We 
consider the positive connection between the 
time spent training a specific goal using the 
robot-assisted device and one of the ICF Body 
Function categories to be particularly important 
evidence. Furthermore, improvement in motoric 
function achieved by affecting afferent sensory 
pathways might be responsible for 
improvement in the Activity and Participation 
category. In order to develop adequate 
recommendations for the use of robot-assisted 
devices in accordance with person-specific 
rehabilitation goals, future research might 
further investigate the relationship between 
robot-assisted training and expected clinical 
improvement. New robot-assisted devices, 
body-powered robots and their possible 
advantages (47) or wearable exoskeleton 
devices that support or replace muscle 
movement initiation (48) are developed 
according to new neurophysiological 
knowledge (49). However, while neurological 
impairment affects a large number of the 
population, overall functional recovery of 
patients with such impairment is limited. As such, 
further investigation of these available devices, 
the assessment of their potential for neurologic 
improvement and any adverse effects is 
required. 
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